Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study

NCT04764006 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: Surufatinib

Sponsor

Fujian Cancer Hospital